UnitedHealth Group (NYSE:UNH) Shares Gap Up After Strong Earnings

UnitedHealth Group Incorporated (NYSE:UNH)’s share price gapped up prior to trading on Tuesday after the company announced better than expected quarterly earnings. The stock had previously closed at $323.48, but opened at $353.01. UnitedHealth Group shares last traded at $354.3990, with a volume of 7,642,045 shares.

The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. The business had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same quarter last year, the business posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 67.02%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beats and stronger results: UNH reported Q1 EPS of $7.23 and revenue of ~$111.6B, topping estimates and signaling improved cost control. VIEW UnitedHealth’s strong first quarter, forecast raise cheer Wall Street
• Positive Sentiment: Guidance uplift: Management raised FY?2026 adjusted EPS guidance to >$18.25, above consensus, which is a clear positive driver for valuation and investor sentiment. UnitedHealth Group Reports First Quarter 2026 Results
• Positive Sentiment: Evidence medical costs easing: Company reported ~ $6.3B net income and said medical?cost trends eased, reducing a major near?term worry for margins. UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease
• Positive Sentiment: Market reaction & analyst support: Shares jumped in early trading and firms have been raising price targets (Jefferies lifted target recently), reflecting renewed analyst conviction. UnitedHealth Stock (UNH) Surges 7%+ on Q1 Earnings Beat – Here’s Why the Market Is Cheering
• Neutral Sentiment: Operational initiatives: UnitedHealthcare expanded rural provider programs (fewer prior authorizations, faster payments) — positives for access and goodwill but longer?term and not an immediate earnings lever. UnitedHealthcare Eliminates Most Medical Prior Authorizations, Accelerates Payments
• Neutral Sentiment: Turnaround narrative: Commentators note this may mark a reversal from last year’s earnings miss, but execution must continue for a sustained recovery. Is UnitedHealth stock a buy after strong earnings?
• Negative Sentiment: Medicare/payment risks remain: Coverage/payment overhauls and a reported potential ~$6B Medicare headwind continue to cloud the durability of margin improvement. UnitedHealth Faces $6 Billion Medicare Hit As Earnings Test Turnaround Progress
• Negative Sentiment: Room for skepticism: Some coverage described Q1 as “flat” in the context of a full comeback — upside priced in by some analysts may require continued margin gains to be justified. UnitedHealth Group Reports Flat First-Quarter Earnings

Analyst Ratings Changes

Several research firms have recently issued reports on UNH. Morgan Stanley lowered their price objective on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a research note on Friday, January 23rd. Jefferies Financial Group raised their price objective on UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a research note on Monday. Piper Sandler reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. Oppenheimer decreased their price target on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a research note on Wednesday, January 28th. Finally, Weiss Ratings lowered UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, March 2nd. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $364.79.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently bought and sold shares of UNH. Sarver Vrooman Wealth Advisors bought a new stake in UnitedHealth Group during the 4th quarter valued at $25,000. Beacon Financial Strategies CORP bought a new stake in UnitedHealth Group during the 4th quarter valued at $26,000. Anfield Capital Management LLC raised its position in UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares in the last quarter. Joseph Group Capital Management bought a new position in shares of UnitedHealth Group in the 4th quarter worth $27,000. Finally, Nalls Sherbakoff Group LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth $27,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 9.3%

The stock has a market capitalization of $321.02 billion, a P/E ratio of 26.81, a price-to-earnings-growth ratio of 1.50 and a beta of 0.40. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. The company has a 50-day moving average price of $287.80 and a 200 day moving average price of $316.94.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.